Literature DB >> 10901441

Effects of triptorelin, a gonadotropin-releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaP.

L Ravenna1, L Salvatori, S Morrone, C Lubrano, M R Cardillo, F Sciarra, L Frati, F Di Silverio, E Petrangeli.   

Abstract

Some analogues of gonadotropin-releasing hormone (GnRH) influence the in vitro proliferation of cultured human cells by complex interactions that are only partially understood. This study explored the effect of Triptorelin, a GnRH agonist, on the LNCaP and PC3 prostatic cell lines, which are, respectively, responsive and unresponsive to androgen stimulation. The toxicity and cell cycle modifications induced by the drug were investigated by FACScan analysis; the effect on cell proliferation in different culture conditions was determined by counting in a Burker chamber; and the expression of binding sites for 125I-Triptorelin was revealed by displacement experiments. PC3 cell growth was completely unaffected by Triptorelin. The drug caused a double stimulatory-inhibitory action on the growth of actively proliferating LNCaP cells, depending upon the dose and environment. A significant inhibitory effect on proliferation, ranging from 25% to 65% compared with controls, was observed at a high dose (10(-4) M) according to the culture conditions; and a proliferative effect (42% compared with controls) was observed at a lower dose (10(-7) M) only in fetal bovine serum-supplemented medium. Displacement experiments revealed the expression of moderately high affinity and low affinity binding sites in LNCaP cells (Kd = 2.6 x 10(-8) and 7.7 x 10(-6) M) but only low affinity binding sites in PC3 cells (Kd = 2.7 x 10(-6) M), which suggests that the expression of binding sites with different affinity could be associated with a biological response to the drug. Proliferation studies in the presence of Cetrorelix, a GnRH antagonist, confirmed the different sensitivity of the 2 cell lines to GnRH analogues and showed that the proliferative effect of Triptorelin on LNCaP cells can be inhibited by the antagonist. Data confirm the cell specificity of Triptorelin's action and the peculiarity of its effects on prostatic cell proliferation in our experimental conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901441

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  7 in total

1.  Goserelin loaded nanoparticles inhibit growth and induce apoptosis in human prostate cancer cell lines.

Authors:  Priti Tomar; Neeti Jain; G S Agarwal; V K Dixit
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

2.  Stability, permeability and growth-inhibitory properties of gonadotropin-releasing hormone liposaccharides.

Authors:  Daryn Goodwin; Pegah Varamini; Pavla Simerska; Istvan Toth
Journal:  Pharm Res       Date:  2014-11-19       Impact factor: 4.200

3.  Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone Analogs.

Authors:  Shayli Varasteh Moradi; Pegah Varamini; Istvan Toth
Journal:  AAPS J       Date:  2015-05-09       Impact factor: 4.009

4.  GnRH receptor expression in human prostate cancer cells is affected by hormones and growth factors.

Authors:  Cristiana Angelucci; Gina Lama; Fortunata Iacopino; Silvia Ferracuti; Aldo V Bono; Robert P Millar; Gigliola Sica
Journal:  Endocrine       Date:  2009-04-28       Impact factor: 3.633

5.  Leuprorelin acetate long-lasting effects on GnRH receptors of prostate cancer cells: an atomic force microscopy study of agonist/receptor interaction.

Authors:  Gina Lama; Massimiliano Papi; Cristiana Angelucci; Giuseppe Maulucci; Gigliola Sica; Marco De Spirito
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

Review 6.  Obesity and metabolic comorbidities: environmental diseases?

Authors:  Carla Lubrano; Giuseppe Genovesi; Palma Specchia; Daniela Costantini; Stefania Mariani; Elisa Petrangeli; Andrea Lenzi; Lucio Gnessi
Journal:  Oxid Med Cell Longev       Date:  2013-03-18       Impact factor: 6.543

7.  Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids.

Authors:  Eszter Lajkó; Sarah Spring; Rózsa Hegedüs; Beáta Biri-Kovács; Sven Ingebrandt; Gábor Mező; László Kőhidai
Journal:  Beilstein J Org Chem       Date:  2018-09-26       Impact factor: 2.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.